DE68910444T2 - 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat. - Google Patents
2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.Info
- Publication number
- DE68910444T2 DE68910444T2 DE89308480T DE68910444T DE68910444T2 DE 68910444 T2 DE68910444 T2 DE 68910444T2 DE 89308480 T DE89308480 T DE 89308480T DE 68910444 T DE68910444 T DE 68910444T DE 68910444 T2 DE68910444 T2 DE 68910444T2
- Authority
- DE
- Germany
- Prior art keywords
- guanidino
- imidazolyl
- pentyl
- thiazole
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1988/003019 WO1990002127A1 (en) | 1988-08-30 | 1988-08-30 | Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino-4-imidazolyl)thiazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68910444D1 DE68910444D1 (de) | 1993-12-09 |
| DE68910444T2 true DE68910444T2 (de) | 1994-03-03 |
Family
ID=22208884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE89308480T Expired - Fee Related DE68910444T2 (de) | 1988-08-30 | 1989-08-22 | 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0357315B1 (enExample) |
| JP (1) | JPH02108690A (enExample) |
| AT (1) | ATE96794T1 (enExample) |
| CA (1) | CA1320207C (enExample) |
| DE (1) | DE68910444T2 (enExample) |
| DK (1) | DK424189A (enExample) |
| ES (1) | ES2059773T3 (enExample) |
| FI (1) | FI94248C (enExample) |
| IE (1) | IE61736B1 (enExample) |
| PT (1) | PT91562B (enExample) |
| WO (1) | WO1990002127A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4621424A (en) * | 1982-09-17 | 1986-11-11 | The Gillette Company | Razor blade assembly |
| US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
| US4632993A (en) * | 1984-10-11 | 1986-12-30 | Pfizer Inc. | Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide |
| ES2054684T3 (es) * | 1986-10-29 | 1994-08-16 | Pfizer | Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo. |
-
1988
- 1988-08-30 WO PCT/US1988/003019 patent/WO1990002127A1/en not_active Ceased
-
1989
- 1989-08-22 ES ES89308480T patent/ES2059773T3/es not_active Expired - Lifetime
- 1989-08-22 DE DE89308480T patent/DE68910444T2/de not_active Expired - Fee Related
- 1989-08-22 EP EP89308480A patent/EP0357315B1/en not_active Expired - Lifetime
- 1989-08-22 AT AT89308480T patent/ATE96794T1/de not_active IP Right Cessation
- 1989-08-28 PT PT91562A patent/PT91562B/pt not_active IP Right Cessation
- 1989-08-28 JP JP1221384A patent/JPH02108690A/ja active Granted
- 1989-08-28 CA CA000609568A patent/CA1320207C/en not_active Expired - Fee Related
- 1989-08-29 DK DK424189A patent/DK424189A/da not_active Application Discontinuation
- 1989-08-29 IE IE276589A patent/IE61736B1/en not_active IP Right Cessation
-
1991
- 1991-02-27 FI FI910956A patent/FI94248C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| DK424189A (da) | 1990-03-01 |
| EP0357315A3 (en) | 1990-08-16 |
| CA1320207C (en) | 1993-07-13 |
| WO1990002127A1 (en) | 1990-03-08 |
| PT91562B (pt) | 1995-05-31 |
| PT91562A (pt) | 1990-03-30 |
| EP0357315A2 (en) | 1990-03-07 |
| ATE96794T1 (de) | 1993-11-15 |
| JPH02108690A (ja) | 1990-04-20 |
| IE61736B1 (en) | 1994-11-30 |
| IE892765L (en) | 1990-02-28 |
| FI94248B (fi) | 1995-04-28 |
| ES2059773T3 (es) | 1994-11-16 |
| DE68910444D1 (de) | 1993-12-09 |
| JPH0456038B2 (enExample) | 1992-09-07 |
| FI94248C (fi) | 1995-08-10 |
| EP0357315B1 (en) | 1993-11-03 |
| DK424189D0 (da) | 1989-08-29 |
| FI910956A0 (fi) | 1991-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0780390B1 (de) | Kristallmodifikation des CDCH, Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| DE60226044T2 (de) | Kristalline formen von fluvastatin-natrium | |
| WO1993010118A1 (de) | Verfahren zur trennung von 5-methyl-tetrahydrofolsäure | |
| DE2708192A1 (de) | Kristalline alpha-form von 2- eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu -4-amino-6,7-dimethoxychinazolin-hydrochlorid und kristalline hydrate von 2- eckige klammer auf 4- (furoyl)-piperazin-1-yl eckige klammer zu -4-amino-6,7-dimethoxychinazolin-hydrochlorid, verfahren zur herstellung dieser kristallinen verbindungen und blutdrucksenkende mittel, die die kristallinen hydrate enthalten | |
| DE2316920B2 (de) | Benzo eckige klammer auf d eckige klammer zu eckige klammer auf 1,3 eckige klammer zu dioxolderivate, deren herstellung und diese enthaltende arzneimittel | |
| DE60131416T2 (de) | Chirale fluochinolon-argininsalzformen | |
| DE69320875T2 (de) | Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung | |
| DE68910444T2 (de) | 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat. | |
| DE2654647C2 (de) | Kristallines Anhydrat von Natrium-7- (D-2-hydroxy-2-phenylacetamido)-3- (1-methyl-1H-tetrazol-5-ylthiomethyl) -3-cephem-4-carboxylat und Verfahren zu seiner Herstellung | |
| DE60003679T2 (de) | Polymorphe eines kristallinen azabicyclo(2,2,2) octan-3-amin citrat und diesen enthaltenden arzneimitteln | |
| DE2060968A1 (de) | Neue Thipyrane und Verfahren zu ihrer Herstellung | |
| DE69025859T2 (de) | Wasserfreie Kristalle von 4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-Olat | |
| DE4235133A1 (de) | Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid | |
| DE2655130C3 (de) | Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes | |
| DE2557033C2 (de) | Acylderivate des 1,2-5,6-Dianhydro-dulcits, Verfahren zu deren Herstellung und diese Verbindungen enthaltende anticarcinogene Mittel | |
| DE2407016A1 (de) | 2-alkoxybenzoylaminosaeuren, verfahren zur herstellung derselben und antipyretisches mittel mit einem gehalt derselben | |
| DE2316721A1 (de) | Neue salze von biguaniden und verfahren zu ihrer herstellung | |
| DE2657770A1 (de) | In 8-stellung aminocarbonyl- und -sulfonylsubstituierte ergoline, ihre verwendung und herstellung | |
| DE3104785A1 (de) | Basische ether der 4-hydroxy-benzophenone, die als (beta)-blocker wirksam sind, und verfahren zu ihrer herstellung | |
| DE69612626T2 (de) | Hydrat-kristall und verfahren zu seiner herstellung | |
| AT265530B (de) | Verfahren zur Herstellung von neuen Isochinolinderivaten | |
| AT282593B (de) | Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen | |
| AT220288B (de) | Verfahren zur Herstellung von neuen therapeutisch wirksamen Estern des Erythromycins | |
| AT258925B (de) | Verfahren zur Herstellung von neuen Pyrimidinderivaten | |
| DE1966641C3 (de) | Verwendung von 4,4-Diarylpiperidinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |